Blood Hemoglobin Substantially Modulates the Impact of Gender, Morbid Obesity, and Hyperglycemia on COVID-19 Death Risk: A Multicenter Study in Italy and Spain

Abstract

BackgroundHyperglycemia and obesity are associated with a worse prognosis in subjects with COVID-19 independently. Their interaction as well as the potential modulating effects of additional confounding factors is poorly known. Therefore, we aimed to identify and evaluate confounding factors affecting the prognostic value of obesity and hyperglycemia in relation to mortality and admission to the intensive care unit (ICU) due to COVID-19.MethodsConsecutive patients admitted in two Hospitals from Italy (Bologna and Rome) and three from Spain (Barcelona and Girona) as well as subjects from Primary Health Care centers. Mortality from COVID-19 and risk for ICU admission were evaluated using logistic regression analyses and machine learning (ML) algorithms.ResultsAs expected, among 3,065 consecutive patients, both obesity and hyperglycemia were independent predictors of ICU admission. A ML variable selection strategy confirmed these results and identified hyperglycemia, blood hemoglobin and serum bilirubin associated with increased mortality risk. In subjects with blood hemoglobin levels above the median, hyperglycemic and morbidly obese subjects had increased mortality risk than normoglycemic individuals or non-obese subjects. However, no differences were observed among individuals with hemoglobin levels below the median. This was particularly evident in men: those with severe hyperglycemia and hemoglobin concentrations above the median had 30 times increased mortality risk compared with men without hyperglycemia. Importantly, the protective effect of female sex was lost in subjects with increased hemoglobin levels.ConclusionsBlood hemoglobin substantially modulates the influence of hyperglycemia on increased mortality risk in patients with COVID-19. Monitoring hemoglobin concentrations seem of utmost importance in the clinical settings to help clinicians in the identification of patients at increased death risk.

Plasma-induced nanoparticle aggregation for stratifying COVID-19 patients according to disease severity

“…6 A), which have also been reported to be dysregulated in patients with severe COVID-19. [31] These data analyses support the idea that our test is detecting patients that require intensive care, which could be useful to stratify them according to disease severity. We then hypothesized that PI dil values could be related to the number of dysregulated prognosis biomarkers that showed a strong correlation in Fig.…”

Survival and risk of death in Covid-19 patients admitted to a public hospital in the Legal Amazon

“…A multicentric study that evaluated 5,345 patients in Italy and Spain, did not find differences in COVID-19 mortality by weight categories (p=0.160), only below normal weight, with BMI < 18.5 kg/m2 being associated (p=0.019) with a higher risk of mortality. However, when analyzing men with severe obesity and hemoglobin levels above the median, there was a higher risk of mortality than in individuals with normal weight, and regarding ICU admission, individuals with obesity had 2-3 times more chances compared to individuals without obesity (Mayneris-Perxachs et al, 2021).…”

Detecting Need-Attention Patients using Machine Learning

“…Many researchers did not study the laboratory variables but only the demographic characteristics of patients, which contribute to the higher hospitalization risk [10]. [11] considering general criteria such as personal, social, and other factors deemed relevant to related disease-specific outcomes can help clinicians detect patients who require attention.…”

“…By using Boruta wrapper feature selection algorithms with CART decision tree, [19] have improved the classification accuracy of medical datasets effectively. Moreover, Boruta has been used to identify the significant features of medical datasets [10], [22], [23], [25]. The researchers recommended Boruta to select relevant variables in high-dimensional datasets [37], [38].…”